0001209191-22-053712.txt : 20221014 0001209191-22-053712.hdr.sgml : 20221014 20221014192550 ACCESSION NUMBER: 0001209191-22-053712 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220826 FILED AS OF DATE: 20221014 DATE AS OF CHANGE: 20221014 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sinclair Andrew CENTRAL INDEX KEY: 0001762451 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36593 FILM NUMBER: 221312368 MAIL ADDRESS: STREET 1: C/O SOLENO THERAPEUTICS INC. STREET 2: 1235 RADIO ROAD, SUITE 110 CITY: REDWOOD CITY STATE: CA ZIP: 94065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLENO THERAPEUTICS INC CENTRAL INDEX KEY: 0001484565 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 770523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 203 REDWOOD SHORES PARKWAY STREET 2: SUITE 500 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-213-8444 MAIL ADDRESS: STREET 1: 203 REDWOOD SHORES PARKWAY STREET 2: SUITE 500 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: Capnia, Inc. DATE OF NAME CHANGE: 20100219 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-26 0 0001484565 SOLENO THERAPEUTICS INC SLNO 0001762451 Sinclair Andrew 203 REDWOOD SHORES PKWY, STE 500 REDWOOD CITY CA 94065 1 0 0 0 Stock option (right to buy) 23.55 2028-12-21 Common Stock 1333 1333 D Stock option (right to buy) 39.45 2029-06-10 Common Stock 823 823 D Stock option (right to buy) 51.15 2030-05-18 Common Stock 635 635 D Stock option (right to buy) 33.60 2031-01-08 Common Stock 2666 2666 D Stock option (right to buy) 15.30 2031-06-01 Common Stock 2124 2124 D Stock option (right to buy) 2.55 2032-06-01 Common Stock 2666 2666 D The per share exercise price and number of shares subject to the option reflect the 1-for-15 reverse stock split effected August 26, 2022. One forty-eighth (1/48th) of the shares subject to the Option shall vest on the first month anniversary of December 21, 2018 (the "Vesting Commencement Date"), and one forty-eighth (1/48th) of the total number of shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), such that all of the shares subject to the Option will have vested as of the fourth anniversary of the Vesting Commencement Date, subject to Reporting Person continuing to be a Service Provider through each such date. All of the shares subject to this option are fully vested and exercisable as of the date hereof. The shares subject to the Option shall vest on the earlier of the twelve-month anniversary of June 1, 2022 or the day before the next annual stockholder meeting, subject to Reporting Person continuing to be a Service Provider through each such date. The Reporting Person is no longer deemed to share an indirect pecuniary interest in the securities held by Abingworth Bioventures VII, LP and therefore no longer reports those securities on his Section 16 reports. /s/ Anish Bhatnagar, Attorney-in-Fact 2022-10-14